Head-To-Head Analysis: SBC Medical Group (NASDAQ:SBC) and AirSculpt Technologies (NASDAQ:AIRS)

AirSculpt Technologies (NASDAQ:AIRS) and SBC Medical Group (NASDAQ:SBC) are both small-cap business services companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, institutional ownership, dividends, profitability, valuation and analyst recommendations.

Volatility & Risk

AirSculpt Technologies has a beta of 1.64, suggesting that its share price is 64% more volatile than the S&P 500. Comparatively, SBC Medical Group has a beta of 0.2, suggesting that its share price is 80% less volatile than the S&P 500.

Earnings and Valuation

This table compares AirSculpt Technologies and SBC Medical Group”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AirSculpt Technologies	$188.78 million	1.64	-$4.48 million	($0.14)	-38.21
SBC Medical Group	$223.34 million	2.79	$340,000.00	N/A	N/A

SBC Medical Group has higher revenue and earnings than AirSculpt Technologies.

Profitability

This table compares AirSculpt Technologies and SBC Medical Group’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
AirSculpt Technologies	-4.13%	2.22%	0.90%
SBC Medical Group	N/A	-11.59%	-7.05%

Analyst Ratings

This is a summary of recent recommendations for AirSculpt Technologies and SBC Medical Group, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AirSculpt Technologies	0	4	0	0	2.00
SBC Medical Group	0	0	0	0	0.00

AirSculpt Technologies presently has a consensus target price of $5.00, suggesting a potential downside of 6.54%. Given AirSculpt Technologies’ stronger consensus rating and higher probable upside, equities research analysts clearly believe AirSculpt Technologies is more favorable than SBC Medical Group.

Institutional and Insider Ownership

91.5% of AirSculpt Technologies shares are owned by institutional investors. Comparatively, 60.8% of SBC Medical Group shares are owned by institutional investors. 78.8% of AirSculpt Technologies shares are owned by insiders. Comparatively, 63.9% of SBC Medical Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

AirSculpt Technologies beats SBC Medical Group on 7 of the 11 factors compared between the two stocks.

About AirSculpt Technologies

AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States. The company offers AirSculpt, a next-generation body contouring procedure that removes unwanted fat and tightens skin in a minimally invasive procedure. It also provides AirSculpt+, a procedure that permanently removes fat and tightens the skin with unparalleled precision and finesse; and AirSculpt Smooth, an advanced cellulite removal tool. In addition, it provides fat removal procedures across treatment areas, such as the stomach, back, and buttocks; and fat transfer procedures that use the patient’s own fat cells to enhance the breasts, buttocks, hips, or other areas. The company’s body contouring procedures also include the Power BBL, a Brazilian butt lift procedure; the Up a Cup, a breast enhancement procedure; and the Hip Flip, an hourglass contouring procedure. It operates various centers. The company was founded in 2012 and is headquartered in Miami Beach, Florida.

About SBC Medical Group

SBC Medical Group Holdings Incorporated, through its subsidiaries, provides services to support the operation of clinics which deliver specialized medical services in the areas of cosmetic medicine, esthetic dentistry and Androgenetic Alopecia or AGA, primarily in Japan and centered on the SBC Shonan Beauty Clinic Brand. SBC Medical Group Holdings Incorporated, formerly known as Pono Capital Two Inc., is based in TOKYO.